相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vivo Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP mgrB Regulator
Antonio Cannatelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Emergence of Colistin Resistance in Enterobacteriaceae after the Introduction of Selective Digestive Tract Decontamination in an Intensive Care Unit
Teysir Halaby et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae
Carlo Tascini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Applying proteomic technology to clinical virology
C. Mancone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013
C Glasner et al.
Eurosurveillance (2013)
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art
Nicola Petrosillo et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Elizabeth B. Hirsch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
Evaluation of Phenotypic and Genotypic Approaches for the Detection of Class A and Class B Carbapenemases in Enterobacteriaceae
Simone Ambretti et al.
MICROBIAL DRUG RESISTANCE (2013)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae
Mahableshwar Albur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Colistin: new lessons on an old antibiotic
D. Yahav et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective
George L. Daikos et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
Grace C. Lee et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2012)
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
O. Zarkotou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii
Madhuri M. Sopirala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Postantibiotic Effects of Tigecycline, Colistin Sulfate, and Levofloxacin Alone or Tigecycline-Colistin Sulfate and Tigecycline-Levofloxacin Combinations against Acinetobacter baumannii
Berna Ozbek et al.
CHEMOTHERAPY (2010)
In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
Azza Elemam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Pharmacokinetic and pharmacodynamic properties of meropenem
David P. Nicolau
CLINICAL INFECTIOUS DISEASES (2008)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
Keith A. Rodvold et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates
L Diancourt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Post-antibiotic and post-β-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum β-lactamase-producing Gram-negative bacteria
JP Lavigne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Determination of minimum inhibitory concentrations
JM Andrews
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
分享论文
